Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The co...
Q2 2026
Feb 12, 2026
Q1 2026
Nov 13, 2025
FY 2025
Sep 29, 2025
Q4 2025
Q3 2025
May 13, 2025